RxDoctor Payments Data

Loyola Gressot

Neurological Surgery · Houston, TXNPI 1366745457

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.4% of the total across 222 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,872, 3.4 times the $1,143 reported in 2019.

$16,900in general payments, 2019–2025

Across 222 payments — averaging $76.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$3K
  • Medtronic$3K
  • Globus Medical$1K
  • Alphatec Spine, Inc$1K
  • Abbott$983
  • Providence Medical Technology, Inc.$977
  • plus $6K from 19 others

What the payments were for

  • Speaking & faculty fees$190%
  • Travel & lodging$1,5999%
  • Food & beverage$15,28290%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,900 in reported general payments places this provider in the 75th percentile of 582 neurological surgery providers in Texas.

See all neurological surgery providers in Texas →

Medicare billing

Part B allowed, 2024
$450,104
Medicare patients
437
Services billed
1,286

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen111$1,728
Methocarbamol88$1,294
Ondansetron OdtOndansetron190$1,022
Minocycline Hcl93$879
Methylprednisolone99$676
Dexamethasone82$444
Mupirocin27$239
Gabapentin40$210
Tizanidine Hcl16$177
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$100

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Houston

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →